COVID-19-vaccine/tamoxifen: Nephropathy and hyperthyroidism.

Předmět:	TAMOXIFEN HYPERTHYROIDISM KIDNEY diseases CONGENITAL disorders BREAST cancer IMMUNIZATION
Zdroj:	Reactions Weekly; 12/9/2023, Vol. 1986 Issue 1, p152-152, 1p
Abstrakt:	Author InformationAn event is serious (based on the ICH definition) when the patient outcome is:• * death * life-threatening * hospitalisation * disability * congenital anomaly * other medically important eventA 49-year-old woman developed nephropathy and hyperthyroidism during treatment with COVID-19-vaccine or tamoxifen for immunisation against COVID-19 or breast cancer [dosages and routes not stated]. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Full text from SpringerLink